about
Disturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric SymptomsRole of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesityAntioxidants, inflammation and cardiovascular diseasePaving the path to HIV neurotherapy: Predicting SIV CNS diseaseImmunomodulatory properties of cacao extracts - potential consequences for medical applicationsMonocytes as regulators of inflammation and HIV-related comorbidities during cARTChloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivityEnvironmental exposures and the development of systemic lupus erythematosusCSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesisUrinary neopterin, a non-invasive marker of mammalian cellular immune activation, is highly stable under field conditionsMIP-Based Sensors: Promising New Tools for Cancer Biomarker Determination.Pharmacokinetic and pharmacodynamic comparison of two "pegylated" interferon alpha-2 formulations in healthy male volunteers: a randomized, crossover, double-blind study.Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort.Comparative Evaluation of Salivary Neopterin Levels and Its Effects to Periodontal Therapy in Pre- and Post-Menopausal WomenTryptophan Metabolism in Allergic DisordersVitamin D, Homocysteine, and Folate in Subcortical Vascular Dementia and Alzheimer DementiaThe innovative development in interferon beta treatments of relapsing-remitting multiple sclerosis.Simultaneous determination of all forms of biopterin and neopterin in cerebrospinal fluid.Serum levels of the immune activation marker neopterin change with age and gender and are modified by race, BMI, and percentage of body fat.Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection.Roles of tetrahydrobiopterin in promoting tumor angiogenesisEarly increase of plasma homocysteine in sepsis patients with poor outcomeMacrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.Serum neopterin is not increased in obese juveniles.Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG) in patients with mycosis fungoides: an open-label trial.Dynamic regulation of phenylalanine hydroxylase by simulated redox manipulationNuclear magnetic resonance based profiling of biofluids reveals metabolic dysregulation in HIV-infected persons and those on anti-retroviral therapyInterferon-γ-induced inflammatory markers and the risk of cancer: the Hordaland Health Study.Pro- and anti-inflammatory cytokines during immune stimulation: modulation of iron status and red blood cell profilePharmacokinetics, pharmacodynamics, and safety of peginterferon beta-1a in subjects with normal or impaired renal function.Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patientsIL-6-independent association of elevated serum neopterin levels with prevalent frailty in community-dwelling older adultsAssociation of detectable cytomegalovirus (CMV) DNA in monocytes rather than positive CMV IgG serology with elevated neopterin levels in community-dwelling older adults.A pharmacokinetic and pharmacodynamic comparison of a novel pegylated recombinant consensus interferon-α variant with peginterferon-α-2a in healthy subjectsBiomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.A prospective study of the immune system activation biomarker neopterin and colorectal cancer risk.Biomarkers for microglial activation in Alzheimer's disease.Lavender oil suppresses indoleamine 2,3-dioxygenase activity in human PBMCIndoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis.GCH1, BH4 and pain
P2860
Q26800052-C5B93364-0570-45E6-8F11-9DE3DA7BF512Q26802171-B34A4F11-6009-43F3-BC5B-061B08EC8A96Q26823009-3349EE43-652D-469E-B198-9AB2995C9D1BQ26852969-514E93AA-5BAD-4F86-9DDF-1D9B73F1227DQ26853328-759ECDF9-B146-4740-A4E5-5769DD65E984Q27006827-D33D84D1-4048-4466-BA9E-A71F199E486EQ28066142-C4035C7B-F70A-45AE-87A9-026D87FA118FQ28385351-DC0332DE-4BA1-460F-A55C-567816AB1A92Q28534309-8D8BCB53-D5EA-47CC-862E-0800311855A6Q28607669-579F8F6A-6D4F-4D3F-9CEA-F082A28085D3Q30356800-5C294DCB-D577-4F5F-B2F8-F37DB9681523Q33392904-9AF563B7-E3D5-4CA7-888F-934164E3B7F0Q33401111-A02E2824-B7ED-4A86-B084-01E379B3F36CQ33689358-BEE67708-EB77-4FB3-916B-2C629EB6EC92Q33693287-FBB3EF83-4AE8-4150-96A1-85939D3EE0C3Q33736457-A901504B-B3A9-4590-998F-798B58A32123Q33810082-C10B01FA-1CE3-4E58-9078-735706E5C0BEQ33918224-A198878D-51B8-4A34-A6D1-2A091A1E9C99Q33993042-6B112241-F1E3-436F-A5D1-D146FC1D9CDDQ34247391-5FBE82B2-22E7-4010-B6EE-59A0EAB8801DQ34254651-A51502A0-8AE6-4002-9050-652C64BADAA2Q34274236-76CDC7EE-29F7-4C8B-9DB2-7A8A106F137EQ34486477-62EEAF6C-226B-4363-B5CB-DAD6C0F67DBFQ34512802-0ABE6B88-6612-4EA2-92AD-6CFEE5557CC3Q34526617-4727C373-9198-447C-B3CF-22EF75A39924Q34541520-7458717F-62B5-4467-B722-87F1CF92F5B4Q34734134-923B12D7-D38F-47F7-9EFE-96C001C83C06Q34819340-3CBD17B8-B439-49BB-B017-4437A4AA2120Q34909510-6D1B0D77-FADE-484A-9D39-55D6EDCE4326Q35004153-0FF0CDF2-34CB-4DCE-BA16-0F772B250FC8Q35009131-C30382FE-7FD4-498C-913D-94C384971452Q35044152-4A0C9751-433B-4466-B6C1-BD5E7B8D360FQ35098797-95061487-F7A1-4D47-8A2F-2D7DADA94470Q35286136-A912811D-2692-489E-91F3-7FA6A40B4592Q35364112-BA674DBA-C830-4E6E-AAA3-3F2B2FB325C0Q35474078-89533722-B459-4E38-9D1B-184890D15812Q35504167-542A7F99-A3CF-487B-9381-0879644F0F51Q35525415-8B3C0C14-D9A2-46F5-B8E5-BAA1DE276050Q35674541-011F9C46-1750-48E7-AB8A-25021158CBB7Q35747905-B2F43905-31DA-485A-85C5-7DCC109672F5
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Neopterin as a marker for immune system activation.
@ast
Neopterin as a marker for immune system activation.
@en
Neopterin as a marker for immune system activation.
@nl
type
label
Neopterin as a marker for immune system activation.
@ast
Neopterin as a marker for immune system activation.
@en
Neopterin as a marker for immune system activation.
@nl
prefLabel
Neopterin as a marker for immune system activation.
@ast
Neopterin as a marker for immune system activation.
@en
Neopterin as a marker for immune system activation.
@nl
P2093
P356
P1476
Neopterin as a marker for immune system activation.
@en
P2093
P304
P356
10.2174/1389200024605082
P407
P577
2002-04-01T00:00:00Z